Cargando…

Lurasidone-induced mania: A case report

INTRODUCTION: Lurasidone is an atypical antipsychotic agent with potential antidepressant effects through its antagonist activity at the 5-HT7 receptor. Although treatment-emergent affective switch (TEAS) induced by second-generation antipsychotics are not frequent, several cases have been reported....

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernández, T., Navarro, L., Marco, O., Tardon, L., Arbelo, N., Ilzarbe, L., Barrio, P., Pacchiarotti, I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564500/ http://dx.doi.org/10.1192/j.eurpsy.2022.1024

Ejemplares similares

Trichotillomania in adulthood, a case report
por: Navarro, L., et al.
Publicado: (2022)

Dhat syndrome: A case report on a culture-bound challenge
por: Ilzarbe, L., et al.
Publicado: (2021)

Anticholinergic syndrome in a patient with schizophrenia
por: Marco Estrada, O., et al.
Publicado: (2022)

Atrial fibrillation debut following first electroconvulsive therapy combined with venlafaxine: a case report and a literature review
por: Ilzarbe, L., et al.
Publicado: (2022)

Cariprazine as a useful treatment for patients with schizophrenia and antipsychotic-induced extrapyramidal symptoms: a case report and literature review
por: Llach, C., et al.
Publicado: (2022)

Lurasidone in treatment of manic episode
por: Sánchez-Rivero, I.
Publicado: (2022)

Mania induced after corticosteroid treatment: a case report
por: Arroyo Sánchez, E., et al.
Publicado: (2023)

Antidepressant-withdrawal mania - a case report
por: Magalhães, M., et al.
Publicado: (2021)

Successful Treatment with Lurasidone of First-Episode Psychosis in Down Syndrome: Case Report and Literature Review
por: Delgado Montfort, L.
Publicado: (2022)

Augmentation strategy fluoxetine and lurasidone in the treatment of OCD with comorbid Restrictive Anorexia: a case report
por: Orsolini, L., et al.
Publicado: (2022)

Lurasidone treatment in a delusional disorder patient with atrial fibrillation: A case report
por: Marini, S., et al.
Publicado: (2021)

Pseudobulbar affect as an early manifestation of HIV-related toxoplasmosis
por: Arbelo, N., et al.
Publicado: (2022)

Terbinafine and antidepressants: Potential risk of medication induced mania
por: Barbosa, P., et al.
Publicado: (2021)

Disulfiram Induced Mania – A Case Report
por: Gupta, Parul, et al.
Publicado: (2022)

Bioenergetic changes and mitochondrial dysfunction in mania versus euthymia in bipolar disorder type I
por: Giménez-Palomo, A., et al.
Publicado: (2023)

Role of MAOI drugs as triggers of manic episodes in bipolar disorders: A case report and a narrative review
por: Olivier Mayorga, L., et al.
Publicado: (2022)

Delirious Mania in an elderly person?: a case report.
por: Setién Preciados, P., et al.
Publicado: (2023)

Pontine hemorrhage as beginning of bipolar disorder or organic mania. A case report
por: Limeres, P. Coucheiro, et al.
Publicado: (2021)

COVID-19 treatment corticosteroids-induced mania
por: Galvañ, J., et al.
Publicado: (2022)

Secondary Mania in Older Adults: a case report and review of literature
por: El Moussaoui, N.
Publicado: (2023)

Lurasidone augmentation to clozapine in treatment resistant schizophrenia: A pilot study
por: Arienti, V., et al.
Publicado: (2023)

Combination therapy in patients with acute bipolar mania
por: Gardabbou, M., et al.
Publicado: (2023)

Corticosteroid induced mania with psychotic symptoms
por: Tavares, F. Gomes, et al.
Publicado: (2021)

Moria or Mania? Manic symptoms as the clinical manifestation of glioblastoma recurrence: a case report
por: Mayor Sanabria, F., et al.
Publicado: (2023)

ECT induced mania in catatonic schizophrenia.
por: Agnihotri, Shruti, et al.
Publicado: (2022)

Lurasidone‐induced hyperosmolar hyperglycemic syndrome: A case report
por: Hanyu, Shota, et al.
Publicado: (2022)

Lurasidone in adolescents with schizophrenia: Sustained remission and recovery during 2 years of open-label treatment
por: Tocco, M., et al.
Publicado: (2021)

Secondary mania related to acquired immunodeficiency syndrome (AIDS). Case report
por: Gliția, D. C., et al.
Publicado: (2023)

Case report: Improvement of chronic mania after Steven-Johnson syndrome
por: Pardo González, C., et al.
Publicado: (2023)

Post-stroke mania
por: Ortega, M.
Publicado: (2022)

Parkinson’s Disease and Bipolar Disorder: a case report and narrative review
por: Andreu Gracia, H., et al.
Publicado: (2022)

Lurasidone-induced Oculogyric Crisis
por: Das, Soumitra, et al.
Publicado: (2017)

Lurasidone-induced Parkinsonism and Hyperprolactinemia
por: Suthar, Navratan, et al.
Publicado: (2019)

Clinical characteristics and sociodemographic profile of patients with First Bipolar Mania
por: Gardabbou, M., et al.
Publicado: (2023)

Neutrocytopenia associated with a lurasidon therapy in a patient with paranoid schizophrenia
por: Mielczarek, Z., et al.
Publicado: (2023)

Double dystonia secondary to risperidone: acute laryngeal dystonia and oculogyric crisis.
por: Tardon, L., et al.
Publicado: (2023)

Existing and emerging pharmacological approaches to the treatment of mania: A critical overview
por: Sparacino, Giulio, et al.
Publicado: (2022)

Dissociative disorder following preeclampsia: A case report
por: Palomo, A. Giménez, et al.
Publicado: (2021)

F60. INFLAMMATORY MARKERS AND COGNITIVE PERFORMANCE IN PATIENTS WITH SCHIZOPHRENIA TREATED WITH LURASIDONE
por: Pikalov, Andrei, et al.
Publicado: (2018)

Neuroleptic Malignant Syndrome: A case report and a literature review
por: De Juan Viladegut, O., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ln7ibe11qhs3af97sqa4e6l4ro